Herbal Products for Gynecological Disorders
DOI:
https://doi.org/10.22270/ajdhs.v2i2.15Keywords:
Menopause, Dysmenorrhea, Premenstrual syndrome, Gynecological disorders, Herbal products, Medicinal plantsAbstract
Herbal products are often used as an alternative to pharmacological therapy. Menopausal symptoms and gynecological disorders (such as premenstrual syndrome and dysmenorrhea) are the indications where pharmacological therapy may have serious adverse events; hence many women prefer to use herbal products to help with these symptoms. Here, we reviewed plants and derived products, which are commonly used for the abovementioned indications, focusing on clinical data, safely profile and whether or not their use is justified. We noted that limited data are available on the use of some plants for alleviating the symptoms of menopause and gynecological disorders. While black cohosh (Cimicifuga racemose) and red clover (Trifolium pretense) were consistently shown to help reduce menopausal symptoms in clinical studies, currently available data do not fully support the use of fenugreek (Trigonella foenum-graecum), hops (Humulus lupulus), valerian (Valeriana officinalis), and soybean (Glycine max and Glycine soja) for this indication. For premenstrual syndrome and premenstrual dysphoric disorder, chaste tree (Vitex agnus-castus) shows effectiveness, but more clinical studies are needed to confirm such effect upon the use of evening primrose (Oenothera biennis).
Keywords: Menopause; Dysmenorrhea; Premenstrual syndrome; Gynecological disorders; Herbal products; Medicinal plants.
References
Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Archives of internal medicine. 2006; 166(14):1453-65. https://doi.org/10.1001/archinte.166.14.1453
Marjoribanks J, Farquhar C, Roberts H, Lethaby A. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane database of systematic reviews. 2012(7). https://doi.org/10.1002/14651858.CD004143.pub4
Yonkers KA, O'Brien PS, Eriksson E. Premenstrual syndrome. The Lancet. 2008; 371(9619):1200-10. https://doi.org/10.1016/S0140-6736(08)60527-9
Bernardi M, Lazzeri L, Perelli F, Reis FM, Petraglia F. Dysmenorrhea and related disorders. F1000Research. 2017; 6. https://doi.org/10.12688/f1000research.11682.1
Dawood MY. Dysmenorrhea. Clinical Obstetrics and Gynecology. 1990; 33(1):168-78. https://doi.org/10.1097/00003081-199003000-00023
Greendale GA, Lee NP, Arriola ER. The menopause. The Lancet. 1999; 353(9152):571-80. https://doi.org/10.1016/S0140-6736(98)05352-5
Kupperman HS, Blatt MH, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. The Journal of Clinical Endocrinology & Metabolism. 1953; 13(6):688-703. https://doi.org/10.1210/jcem-13-6-688
Kanadys W, Barańska A, Błaszczuk A, Polz-Dacewicz M, Drop B, Kanecki K, Malm M. Evaluation of clinical meaningfulness of red clover (Trifolium pratense L.) extract to relieve hot flushes and menopausal symptoms in peri-and post-menopausal women: A systematic review and meta-analysis of randomized controlled trials. Nutrients. 2021; 13(4):1258. https://doi.org/10.3390/nu13041258
Orleans RJ, Li L, Kim MJ, Guo J, Sobhan M, Soule L, Joffe HV. FDA approval of paroxetine for menopausal hot flushes. New England Journal of Medicine. 2014; 370(19):1777-9. https://doi.org/10.1056/NEJMp1402080
Cheema D, Coomarasamy A, El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Archives of gynecology and obstetrics. 2007; 276(5):463-9. https://doi.org/10.1007/s00404-007-0390-9
Handley AP, Williams M. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review. Journal of the American Association of Nurse Practitioners. 2015; 27(1):54-61. https://doi.org/10.1002/2327-6924.12137
Westferry C, Wharf C. Committe on Herbal medicinal Products (HMPC). European Medicines Agency Science Medicines Health. 2010.
Nagulapalli Venkata KC, Swaroop A, Bagchi D, Bishayee A. A small plant with big benefits: Fenugreek (Trigonella foenum‐graecum Linn.) for disease prevention and health promotion. Molecular nutrition & food research. 2017; 61(6):1600950. https://doi.org/10.1002/mnfr.201600950
Sreeja S, Anju VS, Sreeja S. In vitro estrogenic activities of fenugreek Trigonella foenum graecum seeds. Indian Journal of Medical Research. 2010; 131(6):814.
Shabbeer S, Sobolewski M, Anchoori RK, Kachhap S, Hidalgo M, Jimeno A, Davidson NE, Carducci M, Khan SR. Fenugreek: a naturally occurring edible spice as an anticancer agent. Cancer biology & therapy. 2009; 8(3):272-8. https://doi.org/10.4161/cbt.8.3.7443
Srinivasan S, Koduru S, Kumar R, Venguswamy G, Kyprianou N, Damodaran C. Diosgenin targets Akt‐mediated prosurvival signaling in human breast cancer cells. International Journal of Cancer. 2009; 125(4):961-7. https://doi.org/10.1002/ijc.24419
Rao A, Steels E, Beccaria G, Inder WJ, Vitetta L. Influence of a specialized Trigonella foenum‐graecum seed extract (libifem), on testosterone, estradiol and sexual function in healthy menstruating women, a randomised placebo controlled study. Phytotherapy Research. 2015; 29(8):1123-30. https://doi.org/10.1002/ptr.5355
Purohit A, Jain S, Nema P, Jain DK, Vishwakarma H, Jain PK, A Comprehensive Review on Tailoring an Herbal Approach for Treatment of Poly Cystic Ovarian Syndrome, Asian Journal of Dental and Health Sciences. 2022; 2(1):27-32. https://doi.org/10.22270/ajdhs.v2i1.13
Hakimi S, Mohammad Alizadeh S, Delazar A, Abbasalizadeh F, Bamdad Mogaddam R, Siiahi MR, Mostafa Garabagi P. Probable effects of fenugreek seed on hot flash in menopausal women. Journal of Medicinal Plants. 2006; 5(19):9-14.
Khanna A, John F, Das S, Thomas J, Rao J, Maliakel B, Im K. Efficacy of a novel extract of fenugreek seeds in alleviating vasomotor symptoms and depression in perimenopausal women: A randomized, double‐blinded, placebo‐controlled study. Journal of Food Biochemistry. 2020; 44(12):e13507. https://doi.org/10.1111/jfbc.13507
Thomas JV, Rao J, John F, Begum S, Maliakel B, Krishnakumar IM, Khanna A. Phytoestrogenic effect of fenugreek seed extract helps in ameliorating the leg pain and vasomotor symptoms in postmenopausal women: A randomized, double-blinded, placebo-controlled study. PharmaNutrition. 2020; 14:100209. https://doi.org/10.1016/j.phanu.2020.100209
The Plant List: Search Results for Humulus. Available online: http://www.theplantlist.org/tpl1.1/search?q=Humulus.
Bocquet L, Sahpaz S, Hilbert JL, Rambaud C, Rivière C. Humulus lupulus L., a very popular beer ingredient and medicinal plant: Overview of its phytochemistry, its bioactivity, and its biotechnology. Phytochemistry reviews. 2018; 17(5):1047-90. https://doi.org/10.1007/s11101-018-9584-y
Stevens JF, Taylor AW, Deinzer ML. Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. Journal of Chromatography A. 1999; 832(1-2):97-107. https://doi.org/10.1016/S0021-9673(98)01001-2
Stevens JF, Ivancic M, Hsu VL, Deinzer ML. Prenylflavonoids from Humulus lupulus. Phytochemistry. 1997; 44(8):1575-85. https://doi.org/10.1016/S0031-9422(96)00744-3
Chadwick LR, Nikolic D, Burdette JE, Overk CR, Bolton JL, van Breemen RB, Fröhlich R, Fong HH, Farnsworth NR, Pauli GF. Estrogens and Congeners from Spent Hops (Humulus l upulus). Journal of natural products. 2004; 67(12):2024-32. https://doi.org/10.1021/np049783i
Werner RD, Merz AD. Committee on Herbal Medicinal Products (HMPC).
Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L, De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. The Journal of Clinical Endocrinology & Metabolism. 1999; 84(6):2249-. https://doi.org/10.1210/jcem.84.6.5887
Koch W, Heim G. Östrogene Hormone in Hopfen und Bier. Med. Wchnschr. 1953; 95:845.
Trifolium pratense L. Plants of the World Online, Kew Science. Available online: http://www.plantsoftheworldonline.org/taxon/ urn:lsid:ipni.org:names:523575-1.
Trifolium Pratense (Red Clover): Go Botany. Available online: https://gobotany.nativeplanttrust.org/species/trifolium/ pratense.
Lemežienė N, Padarauskas A, Butkutė B, Cesevičienė J, Taujenis L, Norkevičienė E, Mikaliūnienė J. The concentration of isolavones in red clover (Trifolium pratense L.) at lowering stage. Zemdirbyste-Agriculture. 2015; 102(4). https://doi.org/10.13080/z-a.2015.102.057
Nelsen J, Ulbricht C, Barrette EP, Mac DS, Tsouronis C, Rogers A, Basch S, Hashmi S, Bent S, Basch E. Red clover (Trifolium pratense) monograph: a clinical decision support tool. Journal of Herbal Pharmacotherapy. 2002; 2(3):49-72. https://doi.org/10.1080/J157v02n03_06
Messina M, Mejia SB, Cassidy A, Duncan A, Kurzer M, Nagato C, Ronis M, Rowland I, Sievenpiper J, Barnes S. Neither soyfoods nor isoflavones warrant classification as endocrine disruptors: a technical review of the observational and clinical data. Critical Reviews in Food Science and Nutrition. 2022; 62(21):5824-85. https://doi.org/10.1080/10408398.2021.1895054
European Medicines Agency (EMA); Committee on Herbal Medicinal Products (HMPC). EMA/HMPC/150848/2015, Corr. European Union Herbal Monograph on Valeriana officinalis L., Flos; EMA: Amsterdam, The Netherlands; HMPC: London, UK, 2016; 31:1-9.
Hoberg E, Orjala J, Meier B, Sticher O. Diterpenoids from the fruits of Vitex agnus-castus. Phytochemistry. 1999; 52(8):1555-8. https://doi.org/10.1016/S0031-9422(99)00181-8
Usmanghani K, Saeed A, Alam MT. Indusyunic Medicine: Traditional Medicine of Herbal Animal and Mineral Origin in Pakistan. Department of Pharmacognosy, Faculty of Pharmacy, University of Karachi; 1997.
Glycine max subsp. soja (Siebold & Zucc.) H.Ohashi. Plants of the World Online, Kew Science. Available online: http: //www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:920989-1.
Wang KJ, Li XH, Zhang JJ, Chen H, Zhang ZL, Yu GD. Natural introgression from cultivated soybean (Glycine max) into wild soybean (Glycine soja) with the implications for origin of populations of semi-wild type and for biosafety of wild species in China. Genetic Resources and Crop Evolution. 2010; 57(5):747-61. https://doi.org/10.1007/s10722-009-9513-4
Kuroda Y, Kaga A, Tomooka N, Yano H, Takada Y, Kato S, Vaughan D. QTL affecting fitness of hybrids between wild and cultivated soybeans in experimental fields. Ecology and Evolution. 2013; 3(7):2150-68. https://doi.org/10.1002/ece3.606
Xu Z, Ren T, Marowa P, You X, Lu X, Li Y, Zhang C. Establishment of a Cultivation Mode of Glycine soja, the Bridge of Phytoremediation and Industrial Utilization. Agronomy. 2020; 10(4):595. https://doi.org/10.3390/agronomy10040595
Nawaz MA, Lin X, Chan TF, Ham J, Shin TS, Ercisli S, Golokhvast KS, Lam HM, Chung G. Korean wild soybeans (Glycine soja Sieb & Zucc.): Geographic distribution and germplasm conservation. Agronomy. 2020; 10(2):214. https://doi.org/10.3390/agronomy10020214
Murphy PA, Barua K, Hauck CC. Solvent extraction selection in the determination of isoflavones in soy foods. Journal of Chromatography B. 2002; 777(1-2):129-38. https://doi.org/10.1016/S1570-0232(02)00342-2
European Medicines Agency (EMA); Committee on Herbal Medicinal Products (HMPC). EMA/HMPC/220598/2016. Assessment Report on Glycine max (L.) Merr., Lecithinum; EMA: Amsterdam, The Netherlands; HMPC: London, UK, 2017; 31: 2-27.
Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M, Kataoka S, Kubota Y, Kikuchi M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. The Journal of nutrition. 2000; 130(7):1695-9. https://doi.org/10.1093/jn/130.7.1695
Khare B, Jain D, Jain M, Jain D, Khangar PK, Jain DK. An Overview of Lassa fever, an Rising Old World Haemorrhagic Viral Disease, Asian Journal of Dental and Health Sciences. 2022; 2(1):20-26. https://doi.org/10.22270/ajdhs.v2i1.12
Skledar DG, Tvrdý V, Kenda M, Zega A, Pour M, Horký P, Mladěnka P, Dolenc MS, Mašič LP. Applicability of the OECD 455 in-vitro assay for determination of hERa agonistic activity of isoflavonoids. Toxicology and Applied Pharmacology. 2020; 386:114831. https://doi.org/10.1016/j.taap.2019.114831
Messina M. Soy and health update: evaluation of the clinical and epidemiologic literature. Nutrients. 2016; 8(12):754. https://doi.org/10.3390/nu8120754
Pizzorno E, Murray MT. A textbook of Natural Medicine,(4thedn). Churchill livingstone, an imprint of Elservier inc. 2013; 355.
European Medicines Agency (EMA); Committee on Herbal Medicinal Products (HMPC). EMA/HMPC/48744/2017 Assessment report on Cimicifuga racemosa (L.) Nutt., Rhizome; EMA: Amsterdam, The Netherlands; HMPC: London, UK, 2017; 44: 1-64.
European Medicines Agency (EMA); Committee on Herbal Medicinal Products (HMPC). EMA/HMPC/48745/2017 European Union Herbal Monograph on Cimicifuga racemosa (L.) Nutt., Rhizoma; EMA: Amsterdam, The Netherlands; HMPC: London, UK, 2017; 44: 1-8.
Kennelly EJ, Baggett S, Nuntanakorn P, Ososki AL, Mori SA, Duke J, Coleton M, Kronenberg F. Analysis of thirteen populations of black cohosh for formononetin. Phytomedicine. 2002; 9(5):461-7. https://doi.org/10.1078/09447110260571733
He K, Zheng B, Kim CH, Rogers L, Zheng Q. Direct analysis and identification of triterpene glycosides by LC/MS in black cohosh, Cimicifuga racemosa, and in several commercially available black cohosh products. Planta medica. 2000; 66(07):635-40. https://doi.org/10.1055/s-2000-8619
Reame NE, Lukacs JL, Padmanabhan V, Eyvazzadeh AD, Smith YR, Zubieta JK. Black cohosh has central opioid activity in postmenopausal women: Evidence from naloxone blockade and PET neuroimaging studies. Menopause (New York, NY). 2008; 15(5):832. https://doi.org/10.1097/gme.0b013e318169332a
Rhyu MR, Lu J, Webster DE, Fabricant DS, Farnsworth NR, Wang ZJ. Black cohosh (Actaea racemosa, Cimicifuga racemosa) behaves as a mixed competitive ligand and partial agonist at the human μ opiate receptor. Journal of agricultural and food chemistry. 2006; 54(26):9852-7.
https://doi.org/10.1021/jf062808u
Powell SL, Gödecke T, Nikolic D, Chen SN, Ahn S, Dietz B, Farnsworth NR, Van Breemen RB, Lankin DC, Pauli GF, Bolton JL. In vitro serotonergic activity of black cohosh and identification of N ω-methylserotonin as a potential active constituent. Journal of agricultural and food chemistry. 2008; 56(24):11718-26. https://doi.org/10.1021/jf803298z
Cicek SS, Khom S, Taferner B, Hering S, Stuppner H. Bioactivity-guided isolation of GABAA receptor modulating constituents from the rhizomes of Actaea racemosa. Journal of natural products. 2010; 73(12):2024-8. https://doi.org/10.1021/np100479w
Cui G, Leng H, Wang K, Wang J, Zhu S, Jia J, Chen X, Zhang W, Qin L, Bai W. Effects of remifemin treatment on bone integrity and remodeling in rats with ovariectomy-induced osteoporosis. PloS one. 2013; 8(12):e82815. https://doi.org/10.1371/journal.pone.0082815
Choi EM. Deoxyactein stimulates osteoblast function and inhibits bone‐resorbing mediators in MC3T3‐E1 cells. Journal of Applied Toxicology. 2013; 33(3):190-5. https://doi.org/10.1002/jat.1733
Nema P, Jain S, Vishwakarma H, Purohit A, Jain PK. A complete review on aromatherapy: a complementary alternative medication therapy with recent trend. International Journal of Medical Sciences and Pharma Research, 2021; 7(4): 1-7.
Schulz V, Hänsel R, Blumenthal M, Tyler VE. Rational phytotherapy: A reference guide for physicians and pharmacists. Springer Science & Business Media; 2004; 15. https://doi.org/10.1007/978-3-662-09666-6
Certo G, Costa R, D'Angelo V, Russo M, Albergamo A, Dugo G, Germanò MP. Anti-angiogenic activity and phytochemical screening of fruit fractions from Vitex agnus castus. Natural product research. 2017; 31(24):2850-6. https://doi.org/10.1080/14786419.2017.1303696
Chen SN, Friesen JB, Webster D, Nikolic D, van Breemen RB, Wang ZJ, Fong HH, Farnsworth NR, Pauli GF. Phytoconstituents from Vitex agnus-castus fruits. Fitoterapia. 2011; 82(4):528-33. https://doi.org/10.1016/j.fitote.2010.12.003
Masada S. Authentication of the botanical origin of Western herbal products using Cimicifuga and Vitex products as examples. Journal of natural medicines. 2016; 70(3):361-75. https://doi.org/10.1007/s11418-016-1006-0
Oshima N, Masada S, Suzuki R, Yagi K, Matsufuji H, Suenaga E, Takahashi Y, Yahagi T, Watanabe M, Yahara S, Iida O. Identification of new diterpenes as putative marker compounds distinguishing agnus castus fruit (chaste tree) from shrub chaste tree fruit (Viticis fructus). Planta Medica. 2016; 82(01/02):147-53. https://doi.org/10.1055/s-0035-1558089
European Directorate for the Quality of Medicines (EDQM). European Pharmacopoeia (Ph. Eur.), 10th ed.; Council of Europe: Strasbourg, France, 2019.
Vishwakarma H, Thakur K, Purohit A, Jain S, Nema P, Jain PK. A herbal approach for the treatment of kidney stone. International Journal of Medical Sciences and Pharma Research, 2022; 8(1): 1-9.
Oenothera biennis L. Plants of the World Online, Kew Science. Available online: http://www.plantsoftheworldonline.org/taxon/ urn: lsid: ipni.org: names: 172755-2.
Qureshi A, Jain PK, Shrivastava A, Jain S, Nema P, Jain H. Evaluation of antidepressant activity of aqueous and ethanolic extracts of glycyrrhiza glabra. Asian Journal of Pharmaceutical Education and Research, 2022; 11(2): 84-92.
European Medicines Agency (EMA); Committee on Herbal Medicinal Products (HMPC). EMA/HMPC/753041/2017 European Union Herbal Monograph on Oenothera biennis L. or Oenothera lamarckiana L., Oleum; EMA: Amsterdam, The Netherlands; HMPC: London, UK, 2018; 44:1-6.
Cerin A, Collins A, And BM, Eneroth P. Hormonal and biochemical profiles of premenstrual syndrome: treatment with essential fatty acids. Acta obstetricia et gynecologica Scandinavica. 1993; 72(5):337-43. https://doi.org/10.3109/00016349309021108
Horrobin DF. The role of essential fatty acids and prostaglandins in the premenstrual syndrome. The Journal of reproductive medicine. 1983; 28(7):465-8.
Brush MG, Watson SJ, Horrobin DF, Manku MS. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. American Journal of Obstetrics and Gynecology. 1984; 150(4):363-6. https://doi.org/10.1016/S0002-9378(84)80139-8
Puolakka J, Mäkäräinen L, Viinikka L, Ylikorkala O. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. The Journal of reproductive medicine. 1985; 30(3):149-53.
Pye JK, Mansel RE, Hughes LE. Clinical experience of drug treatments for mastalgia. The Lancet. 1985; 326(8451):373-7. https://doi.org/10.1016/S0140-6736(85)92506-1
Massil HY, O'Brien PS. Approach to the management of premenstrual syndrome. Clinical obstetrics and gynecology. 1987; 30(2):443-52. https://doi.org/10.1097/00003081-198706000-00024
Hoberg E, Orjala J, Meier B, Sticher O. Diterpenoids from the fruits of Vitex agnus-castus. Phytochemistry. 1999; 52(8):1555-8. https://doi.org/10.1016/S0031-9422(99)00181-8
Wuttke W, Jarry H, Christoffel V, Spengler B, Seidlova-Wuttke D. Chaste tree (Vitex agnus-castus)-pharmacology and clinical indications. Phytomedicine. 2003; 10(4):348-57. https://doi.org/10.1078/094471103322004866
Marjoribanks J, Brown J, O'Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews. 2013(6). https://doi.org/10.1002/14651858.CD001396.pub3
Kilicdag EB, Tarim E, Bagis T, Erkanli S, Aslan E, Ozsahin K, Kuscu E. Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. International Journal of Gynecology & Obstetrics. 2004; 85(3):292-3. https://doi.org/10.1016/j.ijgo.2004.01.001
Purohit A, Jain S, Nema P, Jain DK, Vishwakarma H, Jain PK. A comprehensive review on tailoring an herbal approach for treatment of poly cystic ovarian syndrome. Asian Journal of Dental and Health Sciences, 2022; 2(1): 27-32.
Jain S, Purohit A, Nema P, Vishwakarma H, Jain PK. A brief review on nutraceuticals and its application. Asian Journal of Dental and Health Sciences, 2022; 2(1): 7-13.
Published
How to Cite
Issue
Section
Citations
Copyright (c) 2022 Harshna Vishwakarma, Sakshi Patel, Sahil Chouksey, Sachin Lodhi, Rituraj Kurmi, Prakhar Nema
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.